Does selenium supplementation during and after pregnancy reduce postpartum thyroid dysfunction and autoimmunity?

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 9, 2007, Pages 624-625

  Lazarus, John H ^a,b  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; SELENOMETHIONINE;

AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NOTE; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SUPPLEMENTATION; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST;

EID: 34548086808     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0581     Document Type: Note

References (5)

1. Negro R et al. (2006) Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 91: 2587-2591
2. Lazarus JH et al. (2002) Postpartum thyroiditis. Autoimmunity 35: 169-173
3. Gärtner R et al. (2002) Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 87: 1687-1691
4. Köhrle J et al. (2005) Selenium, the thyroid, and the endocrine system. Endocr Rev 26: 944-984
5. Lazarus JH and Premawardhana LD (2005) Screening for thyroid disease in pregnancy. J Clin Pathol 58: 449-452